aluates Reports

$ 0.0

Automative

Global Cystic Fibrosis Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-39S13839

Global Cystic Fibrosis Therapeutics Market Insights Forecast to 2029

BUY CHAPTERS

Global Cystic Fibrosis Therapeutics Market Research Report 2025

Code: QYRE-Auto-39S13839

Report

September 2025

Pages:92

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Vertex Pharmaceuticals

F.Hoffmann-La Roche

AbbVie

Gilead Sciences

Novartis

Astrazeneca plc

Bayer

Celtaxsys Inc

Pharmaxis Limited

ProQR Therapeutics

PTC Therapeutics

Alcresta Therapeutics

Insmed Incorporated

Savara

Cyclacel Pharmaceuticals

Vectura

Allergan plc

Cystic Fibrosis Therapeutics Market Size

The global market for Cystic Fibrosis Therapeutics was valued at US$ 6651 million in the year 2024 and is projected to reach a revised size of US$ 15950 million by 2031, growing at a CAGR of 13.5% during the forecast period.

Cystic Fibrosis Therapeutics Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cystic Fibrosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cystic Fibrosis Therapeutics.

The Cystic Fibrosis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cystic Fibrosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cystic Fibrosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cystic Fibrosis Therapeutics Market Report

Report Metric	Details
Report Name	Cystic Fibrosis Therapeutics Market
Accounted market size in year	US$ 6651 million
Forecasted market size in 2031	US$ 15950 million
CAGR	13.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	CFTR Mucolytics PERT Anti-infectives Bronchodilators
Segment by Application	Hospitals Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, AstraZeneca, Bayer, Celtaxsys, Pharmaxis, ProQR Therapeutics, PTC Therapeutics, Alcresta Therapeutics, Insmed Incorporated, Savara, Cyclacel Pharmaceuticals, Vectura, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cystic Fibrosis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cystic Fibrosis Therapeutics Market growing?

Ans: The Cystic Fibrosis Therapeutics Market witnessing a CAGR of 13.5% during the forecast period 2025-2031.

What is the Cystic Fibrosis Therapeutics Market size in 2031?

Ans: The Cystic Fibrosis Therapeutics Market size in 2031 will be US$ 15950 million.

Who are the main players in the Cystic Fibrosis Therapeutics Market report?

Ans: The main players in the Cystic Fibrosis Therapeutics Market are Vertex Pharmaceuticals, F. Hoffmann-La Roche, AbbVie, Gilead Sciences, Novartis, AstraZeneca, Bayer, Celtaxsys, Pharmaxis, ProQR Therapeutics, PTC Therapeutics, Alcresta Therapeutics, Insmed Incorporated, Savara, Cyclacel Pharmaceuticals, Vectura, Allergan

What are the Application segmentation covered in the Cystic Fibrosis Therapeutics Market report?

Ans: The Applications covered in the Cystic Fibrosis Therapeutics Market report are Hospitals, Clinics

What are the Type segmentation covered in the Cystic Fibrosis Therapeutics Market report?

Ans: The Types covered in the Cystic Fibrosis Therapeutics Market report are CFTR, Mucolytics, PERT, Anti-infectives, Bronchodilators

Recommended Reports

Respiratory Disease Therapeutics

Rare & Chronic Disease

Other Therapeutics Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 CFTR

1.2.3 Mucolytics

1.2.4 PERT

1.2.5 Anti-infectives

1.2.6 Bronchodilators

1.3 Market by Application

1.3.1 Global Cystic Fibrosis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cystic Fibrosis Therapeutics Market Perspective (2020-2031)

2.2 Global Cystic Fibrosis Therapeutics Growth Trends by Region

2.2.1 Global Cystic Fibrosis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Cystic Fibrosis Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Cystic Fibrosis Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Cystic Fibrosis Therapeutics Market Dynamics

2.3.1 Cystic Fibrosis Therapeutics Industry Trends

2.3.2 Cystic Fibrosis Therapeutics Market Drivers

2.3.3 Cystic Fibrosis Therapeutics Market Challenges

2.3.4 Cystic Fibrosis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue

3.1.1 Global Top Cystic Fibrosis Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Cystic Fibrosis Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Cystic Fibrosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Cystic Fibrosis Therapeutics Revenue

3.4 Global Cystic Fibrosis Therapeutics Market Concentration Ratio

3.4.1 Global Cystic Fibrosis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cystic Fibrosis Therapeutics Revenue in 2024

3.5 Global Key Players of Cystic Fibrosis Therapeutics Head office and Area Served

3.6 Global Key Players of Cystic Fibrosis Therapeutics, Product and Application

3.7 Global Key Players of Cystic Fibrosis Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Cystic Fibrosis Therapeutics Breakdown Data by Type

4.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2026-2031)

5 Cystic Fibrosis Therapeutics Breakdown Data by Application

5.1 Global Cystic Fibrosis Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Cystic Fibrosis Therapeutics Market Size (2020-2031)

6.2 North America Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Cystic Fibrosis Therapeutics Market Size by Country (2020-2025)

6.4 North America Cystic Fibrosis Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cystic Fibrosis Therapeutics Market Size (2020-2031)

7.2 Europe Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Cystic Fibrosis Therapeutics Market Size by Country (2020-2025)

7.4 Europe Cystic Fibrosis Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cystic Fibrosis Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Cystic Fibrosis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cystic Fibrosis Therapeutics Market Size (2020-2031)

9.2 Latin America Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Cystic Fibrosis Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cystic Fibrosis Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Cystic Fibrosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Vertex Pharmaceuticals

11.1.1 Vertex Pharmaceuticals Company Details

11.1.2 Vertex Pharmaceuticals Business Overview

11.1.3 Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Introduction

11.1.4 Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.1.5 Vertex Pharmaceuticals Recent Development

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Details

11.2.2 F. Hoffmann-La Roche Business Overview

11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Introduction

11.2.4 F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.2.5 F. Hoffmann-La Roche Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Details

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Cystic Fibrosis Therapeutics Introduction

11.3.4 AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.3.5 AbbVie Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Details

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Cystic Fibrosis Therapeutics Introduction

11.4.4 Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.4.5 Gilead Sciences Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Cystic Fibrosis Therapeutics Introduction

11.5.4 Novartis Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.5.5 Novartis Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Cystic Fibrosis Therapeutics Introduction

11.6.4 AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Bayer

11.7.1 Bayer Company Details

11.7.2 Bayer Business Overview

11.7.3 Bayer Cystic Fibrosis Therapeutics Introduction

11.7.4 Bayer Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.7.5 Bayer Recent Development

11.8 Celtaxsys

11.8.1 Celtaxsys Company Details

11.8.2 Celtaxsys Business Overview

11.8.3 Celtaxsys Cystic Fibrosis Therapeutics Introduction

11.8.4 Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.8.5 Celtaxsys Recent Development

11.9 Pharmaxis

11.9.1 Pharmaxis Company Details

11.9.2 Pharmaxis Business Overview

11.9.3 Pharmaxis Cystic Fibrosis Therapeutics Introduction

11.9.4 Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.9.5 Pharmaxis Recent Development

11.10 ProQR Therapeutics

11.10.1 ProQR Therapeutics Company Details

11.10.2 ProQR Therapeutics Business Overview

11.10.3 ProQR Therapeutics Cystic Fibrosis Therapeutics Introduction

11.10.4 ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.10.5 ProQR Therapeutics Recent Development

11.11 PTC Therapeutics

11.11.1 PTC Therapeutics Company Details

11.11.2 PTC Therapeutics Business Overview

11.11.3 PTC Therapeutics Cystic Fibrosis Therapeutics Introduction

11.11.4 PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.11.5 PTC Therapeutics Recent Development

11.12 Alcresta Therapeutics

11.12.1 Alcresta Therapeutics Company Details

11.12.2 Alcresta Therapeutics Business Overview

11.12.3 Alcresta Therapeutics Cystic Fibrosis Therapeutics Introduction

11.12.4 Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.12.5 Alcresta Therapeutics Recent Development

11.13 Insmed Incorporated

11.13.1 Insmed Incorporated Company Details

11.13.2 Insmed Incorporated Business Overview

11.13.3 Insmed Incorporated Cystic Fibrosis Therapeutics Introduction

11.13.4 Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.13.5 Insmed Incorporated Recent Development

11.14 Savara

11.14.1 Savara Company Details

11.14.2 Savara Business Overview

11.14.3 Savara Cystic Fibrosis Therapeutics Introduction

11.14.4 Savara Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.14.5 Savara Recent Development

11.15 Cyclacel Pharmaceuticals

11.15.1 Cyclacel Pharmaceuticals Company Details

11.15.2 Cyclacel Pharmaceuticals Business Overview

11.15.3 Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Introduction

11.15.4 Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.15.5 Cyclacel Pharmaceuticals Recent Development

11.16 Vectura

11.16.1 Vectura Company Details

11.16.2 Vectura Business Overview

11.16.3 Vectura Cystic Fibrosis Therapeutics Introduction

11.16.4 Vectura Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.16.5 Vectura Recent Development

11.17 Allergan

11.17.1 Allergan Company Details

11.17.2 Allergan Business Overview

11.17.3 Allergan Cystic Fibrosis Therapeutics Introduction

11.17.4 Allergan Revenue in Cystic Fibrosis Therapeutics Business (2020-2025)

11.17.5 Allergan Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Vertex Pharmaceuticals

F.Hoffmann-La Roche

AbbVie

Gilead Sciences

Novartis

Astrazeneca plc

Bayer

Celtaxsys Inc

Pharmaxis Limited

ProQR Therapeutics

PTC Therapeutics

Alcresta Therapeutics

Insmed Incorporated

Savara

Cyclacel Pharmaceuticals

Vectura

Allergan plc

List of Tables

Table 1. Global Cystic Fibrosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of CFTR

Table 3. Key Players of Mucolytics

Table 4. Key Players of PERT

Table 5. Key Players of Anti-infectives

Table 6. Key Players of Bronchodilators

Table 7. Global Cystic Fibrosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Cystic Fibrosis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Cystic Fibrosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Cystic Fibrosis Therapeutics Market Share by Region (2020-2025)

Table 11. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Cystic Fibrosis Therapeutics Market Share by Region (2026-2031)

Table 13. Cystic Fibrosis Therapeutics Market Trends

Table 14. Cystic Fibrosis Therapeutics Market Drivers

Table 15. Cystic Fibrosis Therapeutics Market Challenges

Table 16. Cystic Fibrosis Therapeutics Market Restraints

Table 17. Global Cystic Fibrosis Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Cystic Fibrosis Therapeutics Market Share by Players (2020-2025)

Table 19. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2024)

Table 20. Ranking of Global Top Cystic Fibrosis Therapeutics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Cystic Fibrosis Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Cystic Fibrosis Therapeutics, Headquarters and Area Served

Table 23. Global Key Players of Cystic Fibrosis Therapeutics, Product and Application

Table 24. Global Key Players of Cystic Fibrosis Therapeutics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Cystic Fibrosis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2020-2025)

Table 28. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Cystic Fibrosis Therapeutics Revenue Market Share by Type (2026-2031)

Table 30. Global Cystic Fibrosis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2020-2025)

Table 32. Global Cystic Fibrosis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Cystic Fibrosis Therapeutics Revenue Market Share by Application (2026-2031)

Table 34. North America Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Cystic Fibrosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Cystic Fibrosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Cystic Fibrosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Cystic Fibrosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Cystic Fibrosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Cystic Fibrosis Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Cystic Fibrosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Cystic Fibrosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Cystic Fibrosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 49. Vertex Pharmaceuticals Company Details

Table 50. Vertex Pharmaceuticals Business Overview

Table 51. Vertex Pharmaceuticals Cystic Fibrosis Therapeutics Product

Table 52. Vertex Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 53. Vertex Pharmaceuticals Recent Development

Table 54. F. Hoffmann-La Roche Company Details

Table 55. F. Hoffmann-La Roche Business Overview

Table 56. F. Hoffmann-La Roche Cystic Fibrosis Therapeutics Product

Table 57. F. Hoffmann-La Roche Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 58. F. Hoffmann-La Roche Recent Development

Table 59. AbbVie Company Details

Table 60. AbbVie Business Overview

Table 61. AbbVie Cystic Fibrosis Therapeutics Product

Table 62. AbbVie Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 63. AbbVie Recent Development

Table 64. Gilead Sciences Company Details

Table 65. Gilead Sciences Business Overview

Table 66. Gilead Sciences Cystic Fibrosis Therapeutics Product

Table 67. Gilead Sciences Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 68. Gilead Sciences Recent Development

Table 69. Novartis Company Details

Table 70. Novartis Business Overview

Table 71. Novartis Cystic Fibrosis Therapeutics Product

Table 72. Novartis Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 73. Novartis Recent Development

Table 74. AstraZeneca Company Details

Table 75. AstraZeneca Business Overview

Table 76. AstraZeneca Cystic Fibrosis Therapeutics Product

Table 77. AstraZeneca Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 78. AstraZeneca Recent Development

Table 79. Bayer Company Details

Table 80. Bayer Business Overview

Table 81. Bayer Cystic Fibrosis Therapeutics Product

Table 82. Bayer Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 83. Bayer Recent Development

Table 84. Celtaxsys Company Details

Table 85. Celtaxsys Business Overview

Table 86. Celtaxsys Cystic Fibrosis Therapeutics Product

Table 87. Celtaxsys Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 88. Celtaxsys Recent Development

Table 89. Pharmaxis Company Details

Table 90. Pharmaxis Business Overview

Table 91. Pharmaxis Cystic Fibrosis Therapeutics Product

Table 92. Pharmaxis Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 93. Pharmaxis Recent Development

Table 94. ProQR Therapeutics Company Details

Table 95. ProQR Therapeutics Business Overview

Table 96. ProQR Therapeutics Cystic Fibrosis Therapeutics Product

Table 97. ProQR Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 98. ProQR Therapeutics Recent Development

Table 99. PTC Therapeutics Company Details

Table 100. PTC Therapeutics Business Overview

Table 101. PTC Therapeutics Cystic Fibrosis Therapeutics Product

Table 102. PTC Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 103. PTC Therapeutics Recent Development

Table 104. Alcresta Therapeutics Company Details

Table 105. Alcresta Therapeutics Business Overview

Table 106. Alcresta Therapeutics Cystic Fibrosis Therapeutics Product

Table 107. Alcresta Therapeutics Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 108. Alcresta Therapeutics Recent Development

Table 109. Insmed Incorporated Company Details

Table 110. Insmed Incorporated Business Overview

Table 111. Insmed Incorporated Cystic Fibrosis Therapeutics Product

Table 112. Insmed Incorporated Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 113. Insmed Incorporated Recent Development

Table 114. Savara Company Details

Table 115. Savara Business Overview

Table 116. Savara Cystic Fibrosis Therapeutics Product

Table 117. Savara Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 118. Savara Recent Development

Table 119. Cyclacel Pharmaceuticals Company Details

Table 120. Cyclacel Pharmaceuticals Business Overview

Table 121. Cyclacel Pharmaceuticals Cystic Fibrosis Therapeutics Product

Table 122. Cyclacel Pharmaceuticals Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 123. Cyclacel Pharmaceuticals Recent Development

Table 124. Vectura Company Details

Table 125. Vectura Business Overview

Table 126. Vectura Cystic Fibrosis Therapeutics Product

Table 127. Vectura Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 128. Vectura Recent Development

Table 129. Allergan Company Details

Table 130. Allergan Business Overview

Table 131. Allergan Cystic Fibrosis Therapeutics Product

Table 132. Allergan Revenue in Cystic Fibrosis Therapeutics Business (2020-2025) & (US$ Million)

Table 133. Allergan Recent Development

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

Table 137. Authors List of This Report

List of Figures

Figure 1. Cystic Fibrosis Therapeutics Picture

Figure 2. Global Cystic Fibrosis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Cystic Fibrosis Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. CFTR Features

Figure 5. Mucolytics Features

Figure 6. PERT Features

Figure 7. Anti-infectives Features

Figure 8. Bronchodilators Features

Figure 9. Global Cystic Fibrosis Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Cystic Fibrosis Therapeutics Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Cystic Fibrosis Therapeutics Report Years Considered

Figure 14. Global Cystic Fibrosis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Cystic Fibrosis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Cystic Fibrosis Therapeutics Market Share by Region: 2024 VS 2031

Figure 17. Global Cystic Fibrosis Therapeutics Market Share by Players in 2024

Figure 18. Global Top Cystic Fibrosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cystic Fibrosis Therapeutics as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Cystic Fibrosis Therapeutics Revenue in 2024

Figure 20. North America Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Cystic Fibrosis Therapeutics Market Share by Country (2020-2031)

Figure 22. United States Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Cystic Fibrosis Therapeutics Market Share by Country (2020-2031)

Figure 26. Germany Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Cystic Fibrosis Therapeutics Market Share by Region (2020-2031)

Figure 34. China Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Cystic Fibrosis Therapeutics Market Share by Country (2020-2031)

Figure 42. Mexico Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Cystic Fibrosis Therapeutics Market Share by Country (2020-2031)

Figure 46. Turkey Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Cystic Fibrosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Vertex Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 51. AbbVie Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 52. Gilead Sciences Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 53. Novartis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 54. AstraZeneca Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 55. Bayer Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 56. Celtaxsys Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 57. Pharmaxis Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 58. ProQR Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 59. PTC Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 60. Alcresta Therapeutics Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 61. Insmed Incorporated Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 62. Savara Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 63. Cyclacel Pharmaceuticals Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 64. Vectura Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 65. Allergan Revenue Growth Rate in Cystic Fibrosis Therapeutics Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Cystic Fibrosis Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Critical Care Therapeutics Market Research Report 2025

Global Still s Disease Treatment Market Research Report 2025

Global Chronic Kidney Disease Drugs Market Research Report 2025

Idiopathic Pulmonary Fibrosis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Treatment Planning Software Market Research Report 2025

Global Combination Therapy Drug Market Research Report 2025

Global Cardiovascular Disease Nursing Drugs Market Research Report 2025

Global Pharmaceutical Grade 2 Cyanopyridine Market Research Report 2025

Global Diagnostic Guidewire Market Research Report 2024

Global Asthma Therapeutics Market Research Report 2025

Global Pharmaceutical Filter Aid Market Research Report 2025

Global Gynecological Cancers Drug Market Research Report 2025

Global Pharmaceutical Asset Management Market Research Report 2025

Global Drug Safety and Pharmacovigilance Service Market Research Report 2025

Global Reproductive and Fertility Diagnosis Market Research Report 2025

Cystic Acne Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Screening Test Kit Market

Global Pharmaceutical Validation Services Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions